Follicum finalises patient recruitment in hair growth study - BioStock
2019 in review: Follicum ready for phase II with hair loss candidate - BioStock
All patients included in Follicum's Phase II study with FOL-005 for stimulation of hair growth
Female alopecia – new solutions on the horizon - BioStock
Follicum reports revised top-line results from the Phase IIa study of FOL-005 for the treatment of hair loss (alopecia)
The game changer for stimulation of hair growth and thickness.
Tissue Repair Peptides
Follicum tar in kapital från tunga investerare - YouTube
Utvecklingsplan topikal formulering - Follicum
Trading Direkt analyserar bolagen på Spotlight 2018-10-11: Smoltek & Follicum - YouTube
Follicums vd Kim Arvid Nielsen får sparken | Realtid
About us - Follicum
About us - Follicum
Start - Follicum
First-in-man study appears to 'awaken' dormant hair follicles, says biotech
Follicum förstärker sin kliniska expertis inom diabetes och inrättar vetenskapligt råd med toppforskare | Diabetes Wellness Sverige
Follicum receives European patent for the company's peptides for developing first in class diabetes treatments
Market Notice 11/22 – Follicum AB will be delisted after close of the market on February 3, 2022
ÅRSREDOVISNING
Nyemission i Follicum AB på Spotlight - Aktier
Follicum Comes Back To Share New FOL005 Presentation May 2023 - Follicle Thought
Trading Direkt analyserar bolagen på Spotlight - YouTube
Folicum - Corporate Presentation - slutversion web
Tissue Repair Peptides
Slutgiltigt godkänt patent för Follicum » Finanstid
